Cargando…
C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells
BACKGROUND: Tamoxifen is a frontline therapy for estrogen receptor (ER)-positive breast cancer in premenopausal women. However, many patients develop resistance to tamoxifen, and the mechanism underlying tamoxifen resistance is not well understood. Here we examined whether ER-c-Src-HER2 complex form...
Autores principales: | Li, Wei, Xu, Ling, Che, Xiaofang, Li, Haizhou, Zhang, Ye, Song, Na, Wen, Ti, Hou, Kezuo, Yang, Yi, Zhou, Lu, Xin, Xing, Xu, Lu, Zeng, Xue, Shi, Sha, Liu, Yunpeng, Qu, Xiujuan, Teng, Yuee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930956/ https://www.ncbi.nlm.nih.gov/pubmed/29720121 http://dx.doi.org/10.1186/s12885-018-4387-5 |
Ejemplares similares
-
MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma
por: Li, Ce, et al.
Publicado: (2018) -
E3 Ubiquitin Ligase Cbl-b Prevents Tumor Metastasis by Maintaining the Epithelial Phenotype in Multiple Drug-Resistant Gastric and Breast Cancer Cells()
por: Xu, Ling, et al.
Publicado: (2017) -
DR5‐Cbl‐b/c‐Cbl‐TRAF2 complex inhibits TRAIL‐induced apoptosis by promoting TRAF2‐mediated polyubiquitination of caspase‐8 in gastric cancer cells
por: Xu, Ling, et al.
Publicado: (2017) -
The E3 Ubiquitin Ligase Cbl-b Predicts Favorable Prognosis in Breast Cancer
por: Liu, Xiuming, et al.
Publicado: (2020) -
Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance
por: Feng, Jing, et al.
Publicado: (2020)